9.45 0.06 (0.64%)

27.02% Gain from 52W Low

199.9K XNAS Volume

XNAS 20 May, 2025 4:05 PM (EDT)

Board Meeting
The board meeting for Theravance Biopharma Inc is scheduled for today, for the purpose of H.C. Wainwright 3rd Annual BioConnect Investor Conference See details

Theravance Biopharma Inc - TBPH - stock price prediction, stock price target, analyst ratings from 4 analysts

Theravance Biopharma Inc has a share price target of US$ 15, revenue growth forecast of 40.0%, and profit growth estimate of 60.2% for FY25, based on top 4 analyst calls.